Articles from Medical Laboratory Observer (June 1, 2002)

1-33 out of 33 article(s)

Title	Author	Type	Words
Abbott gets sole-source deal from Red Cross. (Blood Bank).		Brief Article	79
Accurate, flexible, simple. (Product Watch).			79
Answering your questions on moving regular meeting times, scheduling vacations, and resisting change. (Management Q & A).	Frings, Christopher S.		3505
Anti-roll innovation. (Product Watch).			74
Beckman Coulter and NDC ink deal. (Industry Watch).		Brief Article	70
Blood documentary to air. (Blood Bank).		Brief Article	119
Cardiac markers: cost-effective triage for MI admission and therapy.	Wu, Alan H. B.		2383
Chemistry analyzers: Setting the stage for success. (Product roundup).	Noble, Suzanne		1201
Colorimetric methodology. (Product Watch).			52
Controversies and guidelines in tissue-based HER-2/neu testing in breast cancer.	Yaziji, Hadi; Gown, Allen M.		4377
Fisher to distribute for DiaSys. (Industry Watch).		Brief Article	72
From the editor.	Stevens, Celia		499
Gene testing holds promise for lucrative future. (News).		Brief Article	113
HHS issues guidelines on disaster readiness for ventilation systems. (News).		Brief Article	89
Higher level evaluation. (Product Watch).			80
Incorporating HIPAA-relevant language into new vendor agreements. (Liability and the Lab).	Harty-Golder, Barbara	Brief Article	852
It's a gas: HPG contracts with Roche Diagnostics. (Industry Watch).		Brief Article	108
Lab temperature control, clue cells, Kleihauer-Betke stain, fixing AFB smears, and sweat test utilization. (Tips from the Clinical Experts).	Baer, Daniel M.		1874
Latest changes to HIPAA still have problems; complying with OSHA needlestick directive. (Washington Report).	Szabo, Joan	Brief Article	704
Medical laboratory industry -- 2007: talking with Catherine Burzik, President, Ortho-Clinical Diagnostics Inc. (In the Eyes of the Experts).	Pontius, C. Anne	Interview	1992
New cardiac risk indicator. (Product Watch).			85
Pipette tracker. (Product Watch).			81
Positive and negative controls. (Product Watch).			85
SciQuest inks e-procurement deal with GlaxoSmithKline. (Industry Watch).		Brief Article	93
Selectively quick. (Product Watch).			105
Setting the pace. (Product Watch).			69
Study examines cost-effectiveness of treatment interventions for Type 2 diabetes. (News).		Brief Article	222
Subjectivity-free assay. (Product Watch).			75
The spin is on. (Product Watch).			71
Thrombosis risk alert. (Product Watch).			70
Water free, catalyst free. (Product Watch).			62
Winged peace of mind. (Product Watch).			105
Worth noting.		Brief Article	251